Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas
Cancer Research, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Cancer Cell, 2021
Diagnostic Utility of RNA-Seq for Evaluation of PD-L1 Expression in Clear Cell Renal Cell Carcinoma
Clinical Genitourinary Cancer, 2021
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
Blood Cancer Journal, 2021
The development of a computational machine learning tool to decipher malignant cell gene expression from complex tumor tissue
Journal of Clinical Oncology, 2021
Analytical and clinical validation of the BostonGene tumor portrait assay
Journal of Clinical Oncology, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Journal for ImmunoTherapy of Cancer, 2021
Tumor immune microenvironment based molecular functional clustering reveals a prognostic signature that predicts overall survival in patients with gastric cancer
Cancer Research, 2021
Predictors of treatment response in a preoperative window of opportunity trial of nivolumab in resectable squamous cell carcinoma of the head and neck
Cancer Research, 2021
MutAnt: Mutation annotation machine learning algorithm for pathogenicity evaluation of single nonsynonymous nucleotide substitutions in cancer cells
Cancer Research, 2021
Questions
Contact us